ArticleMolecular oncology2025

Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma.

Brandon Ramchatesingh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.